Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...
There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...